Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Inventor:
Vlasuk; George P.
Address:
Carlsbad, CA
No. of patents:
14
Patents:












Patent Number Title Of Patent Date Issued
7329640 Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor February 12, 2008
The present invention provides methods of treating hemorrhagic fevers where selective inhibitors of fVIIa/TF are used as a treatment for hemorrhagic fevers and have therapeutic effects which include ameliorating and/or preventing coagulopathy and inflammatory responses. These inhibit
7132398 Method of treatment of hemorrhagic disease using a factor VIIa/tissue factor inhibitor November 7, 2006
The present invention provides methods of treating hemorrhagic fevers where selective inhibitors of fVIIa/TF are used as a treatment for hemorrhagic fevers and have therapeutic effects which include ameliorating and/or preventing coagulopathy and inflammatory responses. These inhibit
6962795 Neutrophil inhibitors November 8, 2005
Compositions enriched for Neutrophil Inhibitory Factor which inhibit neutrophil activity including adhesion to vascular endothelial cells are provided. Also provided are recombinant Neutrophil Inhibitory Factors which also which inhibit neutrophil activity. Such compositions may comp
6818616 Neutrophil inhibitors November 16, 2004
Compositions enriched for Neutrophil Inhibitory Factor which inhibit neutrophil activity including adhesion to vascular endothelial cells are provided. Also provided are recombinant Neutrophil Inhibitory Factors which also which inhibit neutrophil activity. Such compositions may comp
6756211 Neutropohil inhibitors June 29, 2004
Compositions enriched for Neutrophil Inhibitory Factor which inhibit neutrophil activity including adhesion to vascular endothelial cells are provided. Such compositions may comprise a glycoprotein isolated from nematodes. These compositions are useful in the therapy of conditions wh
5886146 Inhibitors of thrombosis March 23, 1999
This invention relates to peptide aldehyde analogs that inhibit the thrombin or Factor Xa. The compounds are thought useful for preventing or treating conditions in mammal characterized by abnormal thrombosis.
5789178 Neutrophil inhibitors August 4, 1998
Compositions enriched for Neutrophil Inhibitory Factor which inhibit neutrophil activity including adhesion to vascular endothelial cells are provided. Also provided are recombinant Neutrophil Inhibitory Factors which also which inhibit neutrophil activity. Such compositions may comp
5747296 Method of detecting neutophil inhibitory factor mimics May 5, 1998
Compositions enriched for Neutrophil Inhibitory Factor which inhibit neutrophil activity including adhesion to vascular endothelial cells are provided. Also provided are recombinant Neutrophil Inhibitory Factors which also which inhibit neutrophil activity. Such compositions may comp
5708141 Neutrophil inhibitors January 13, 1998
Compositions enriched for Neutrophil Inhibitory Factor which inhibit neutrophil activity including adhesion to vascular endothelial cells are provided. Such compositions may comprise a glycoprotein isolated from nematodes, particularly of the genus Ancylostoma. These compositions are
5670479 .alpha.-ketoamide derivatives as inhibitors of thrombosis September 23, 1997
a-Ketoamide derivatives, their pharmaceutically acceptable salts, compositions, diagnostic compositions and pharmaceutical compositions, which are useful for preventing or treating in a mammal a pathological condition characterized by thrombosis are described.a-Ketoamide derivatives, the
5656600 .alpha.-ketoamide derivatives as inhibitors of thrombosis August 12, 1997
.alpha.-Ketoamide derivatives, their pharmaceutically acceptable salts, compositions, diagnostic compositions and pharmaceutical compositions, which are useful for preventing or treating in a mammal a pathological condition characterized by thrombosis are described..alpha.-Ketoamide deri
5597804 N-sulfonylarginine keto-amide compounds January 28, 1997
The present invention is directed to N-sulfonyl arginine alpha-keto-amide derivatives, their pharmaceutically acceptable salts and compositions thereof which are useful as antithrombotic agents in mammals and also the use of these compounds as antithrombotic agents. Also, disclosed are
5492895 Inhibitors of thrombosis February 20, 1996
This invention relates to peptide aldehyde analogs that inhibit the thrombin or Factor Xa. The compounds are thought useful for preventing or treating conditions in mammal characterized by abnormal thrombosis.
5371072 Asp-Pro-Arg .alpha.-keto-amide enzyme inhibitors December 6, 1994
Asp-Pro-Arg alpha-keto-amide derivatives, and their pharmaceutically acceptable salts and compositions, for use as antithrombotic agents in mammals are disclosed. The method of use of these inhibitor compounds for treatment or prevention of conditions of abnormal thrombus formation in










 
 
  Recently Added Patents
Method for producing lactamates by way of thin film evaporation
Integrated circuits with magnetic core inductors and methods of fabrications thereof
Weighted determination in configuration management systems
Scalable architecture for rank order filtering
Organic light emitting display apparatus
Television receiver
Head shield
  Randomly Featured Patents
Oxidation catalysts for engines producing low temperature exhaust streams
Process cartridge and image forming apparatus
Flag with replaceable panels
Method and apparatus for dispersing liquids or melts
Magnetic tunnel junction patterning using Ta/TaN as hard mask
Implants and methods for posterior dynamic stabilization of a spinal motion segment
Circulating load apparatus
Stable aqueous epoxy dispersions
Method and apparatus for supporting memory usage throttling
Method for operating a device with redundant power supply units and a power supply apparatus with redundant power supply units